Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Press Barbados.
Press releases published on July 10, 2025
NKGen Biotech Administers First Dose of Troculeucel to Alzheimer’s Patient Who Continued to Decline Cognitively While on Prior Amyloid-Targeting Therapy
GlobeNewswire
·
July 10, 2025
SANTA ANA, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer …
Crinetics Pharmaceuticals Announces July 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 10, 2025
SAN DIEGO, July 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on July 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of …
Serina Therapeutics Makes Grant to New Employee Under Inducement Plan
GlobeNewswire
·
July 10, 2025
HUNTSVILLE, AL, July 10, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company advancing its lead IND candidate SER-252 for advanced Parkinson's disease, enabled by its proprietary POZ …
Alignment Healthcare to Announce Second Quarter 2025 Financial Results and Host Conference Call Wednesday, July 30, 2025
GlobeNewswire
·
July 10, 2025
ORANGE, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its second quarter 2025 financial results on Wednesday, July 30, after market close. Following the release, the company will host a conference call to …
Jupiter Neurosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement
GlobeNewswire
·
July 10, 2025
Nasdaq compliance follows positive upward trend in Company’s Stock Price Jupiter, Florida, July 10, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company developing JOTROL …
Maze Therapeutics to Participate in Two Upcoming Investor Conferences
GlobeNewswire
·
July 10, 2025
SOUTH SAN FRANCISCO, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with renal, metabolic and cardiovascular diseases, …
Iovance Biotherapeutics Appoints Marc R. Theoret, M.D. as Senior Vice President, Regulatory Strategy
GlobeNewswire
·
July 10, 2025
SAN CARLOS, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for …
Cogent Biosciences Announces Closing of Upsized Public Offering of Shares of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
GlobeNewswire
·
July 10, 2025
WALTHAM, Mass. and BOULDER, Colo., July 10, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the closing of its previously …
Vor Bio Appoints Veteran Biotech Executive Sandy Mahatme as Chief Financial Officer and Chief Business Officer
GlobeNewswire
·
July 10, 2025
Mr. Mahatme brings decades of experience in strategic finance, capital formation, and operational leadership to support company’s transformation and growth in autoimmune disease CAMBRIDGE, Mass., July 10, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a …
Brookdale and Monmouth Medical Center Launch Partnership to Expand Nursing Education and Workforce Pathways
GlobeNewswire
·
July 10, 2025
Lincroft, NJ, July 10, 2025 (GLOBE NEWSWIRE) -- Brookdale Community College and Monmouth Medical Center (MMC) have entered into an agreement to expand educational and career opportunities for aspiring nurses in Monmouth County. The formal partnership …
Tevogen’s New Headquarters, Fully Funded by CEO, Centralizes R&D and AI Teams to Accelerate Innovation
GlobeNewswire
·
July 10, 2025
CEO's personal contribution fully funds build-out and first-year operations Doubled HQ footprint centralizes cross-functional teams, including research, regulatory affairs, and the expanding Tevogen.AI initiative WARREN, N.J., July 10, 2025 (GLOBE NEWSWIRE …
Slipstream Co-Authors First Comprehensive Cost Study on Hereditary Hemorrhagic Telangiectasia in the American Journal of Hematology
GlobeNewswire
·
July 10, 2025
BLUE BELL, Pa., July 10, 2025 (GLOBE NEWSWIRE) -- Slipstream, a trusted technology partner serving the Pharmaceutical and Biopharmaceutical industry, is proud to announce its co-authorship of a groundbreaking study on Hereditary Hemorrhagic Telangiectasia …
CAR T-Cell Therapy Market to Surge at 40.2% CAGR Over the Next Five Years
GlobeNewswire
·
July 10, 2025
Boston, July 10, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Current R…
Biologic Competition, Payer Pressures, and Gene Therapy Momentum Define a Pivotal Moment in nAMD and DME Management, According to Spherix Global Insights
GlobeNewswire
·
July 10, 2025
Exton, Pennsylvania, July 10, 2025 (GLOBE NEWSWIRE) -- Recently released research from Spherix Global Insights provides a timely look at the increasingly competitive and complex treatment landscape for neovascular age-related macular degeneration (nAMD) …
Cannabinoid Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
GlobeNewswire
·
July 10, 2025
New York, USA, July 10, 2025 (GLOBE NEWSWIRE) -- Cannabinoid Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight The cannabinoid agonist market is gaining momentum due to …
Interleukin-2 Inhibitors Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
GlobeNewswire
·
July 10, 2025
New York, USA, July 10, 2025 (GLOBE NEWSWIRE) -- Interleukin-2 Inhibitors Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight Interleukin-2 (IL-2) inhibitors are immunosuppressive agents …
Canadian Red Cross and Walmart Canada launch annual giving campaign
GlobeNewswire
·
July 10, 2025
OTTAWA, Ontario, July 10, 2025 (GLOBE NEWSWIRE) -- The Canadian Red Cross, in collaboration with Walmart Canada, is pleased to announce its annual giving campaign in support of emergency response. For the month of July, Walmart customers across Canada will …
La Croix-Rouge canadienne et Walmart Canada lancent leur campagne de financement annuelle
GlobeNewswire
·
July 10, 2025
OTTAWA, Ontario, 10 juill. 2025 (GLOBE NEWSWIRE) -- En collaboration avec Walmart Canada, la Croix-Rouge canadienne a le plaisir d’annoncer le lancement de sa campagne de collecte de fonds annuelle au profit de ses programmes d’intervention d’urgence. Au …
Canopy and Commure Announce Strategic Partnership to Advance Staff Safety in Healthcare
GlobeNewswire
·
July 10, 2025
SAN FRANCISCO, July 10, 2025 (GLOBE NEWSWIRE) -- Canopy, a leader in wearable safety and real-time location systems (RTLS) for healthcare, and Commure, the company behind next-generation AI infrastructure for health systems, today announced a strategic …
Annette Slyman brings Global Marketing, Commercial and Operational Experience to Galacxia, Inc. as Chief Operating Officer of Life Backup Plan App
GlobeNewswire
·
July 10, 2025
Aliso Viejo, CA, July 10, 2025 (GLOBE NEWSWIRE) -- Galacxia, Inc., creator of the Life Backup Plan app, proudly announces the appointment of Annette Slyman as Chief Operating Officer. Slyman brings three decades of strategic leadership and transformational …